Call
+918447748545

Published on: Jul 22, 2020
2 minute read
By: Dr Rajan Choudhary

The Oxford Vaccine

Recently we wrote a blog on the success of an RNA vaccine against SARS-CoV-2, the virus responsible for COVID-19. Within just a few weeks of that incredible research breakthrough, researchers at Oxford University’s Jenner Institute have announced a COVID vaccine that has induced remarkable immune response against the virus.

This study was published in the Lancet, one of the most prestigious medical journals in the world, and a simple summary suggests the vaccine has no early safety concern and is able to induce a strong immune response with both T cells and B cell/antibodies.

THE VACCINE

ChAdOx1 nCoV-19, now known as AZD1222, was co-developed by the University of Oxford and one of its spin-off companies, Vaccitech. The vaccine uses a viral vector based on a common cold virus (adenovirus). This carries genetic material for the SARS-CoV-2 spike protein. In our previous blog, we saw how the spike proteins are used by the virus to target and fuse with our target cells, allowing the virus to invade, replicate and ultimately cause the disease known as COVID. It is also a good target for the human immune system to recognize and attack.

The viral vector delivers the genetic material inside our cells. The spike protein is then produced by our cells, recognized by the immune system as a viral target, and an immune response is created against it. This can be antibodies, which recognize, attach to and mark the virus in our blood, allowing for other white blood cells to destroy the virus.

In this case, the vaccine also produced a T cell response. T cells can recognize cells infected by a virus-based on the markers present on the surface of infected cells. They can tell an infected cell to destroy itself, thereby destroying the virus within without spreading the infection. They also have other functions that we will not discuss in this blog.

THE STUDY

This study was a Phase I/II trial that started in April using the vaccine named ChAdOx1 nCoV-19. This vaccine development started in January 2020, and progress on development has been incredibly rapid. Whilst our previous study had just 45 people, this study looked reviewed over 1,000 healthy adults. 10 of these participants received two doses of the vaccine.

In a study the more participants there are, the greater the power of the study. If the vaccine has any side effects, even ones that rarely occur, it is more likely to be picked up in studies with more people. Similarly having more people helps show that the vaccine is effective, and the strong responses are not merely a fluke or accident. Another benefit of this study is it was able to compare the vaccine against a control group. This shows the results were not simply a placebo and allowed comparison of side effects as well.

The majority of side effects were feeling feverish, chills, muscle ache, headache, and malaise, all symptoms treatable with paracetamol. None of the participants had any serious side effects. It took just 14 days to create a T cell response, and 28 days to make strong antibodies. In 91% of patients, this was enough to neutralize the COVID coronavirus. Receiving two doses gave an even stronger antibody response, and all participants were able to stop the virus.

WHAT NEXT

The news from the University of Oxford is needed, as infection rate and mortality continue to increase in countries such as the US and Brazil. The ability to induce an antibody response without causing harm to the patient shows we have made huge progress in the fight against COVID-19. Further Large scale Phase III trials been set up through a global partnership, and include studies in the US with over 30,000 patients, studies in children as well as some in low to middle-income countries.

If successful a vaccine would be essential in preventing a second wave of COVID in the winter when the elderly population is most at risk. And it would be the key to restarting the economy and getting our everyday lives back to where it was pre-pandemic.

Read Blog

How Weekly Onsite Yoga Benefits Corporate Wellness: A Preventive Approach to Workplace Health

Corporate wellness programs are evolving rapidly. Traditional initiatives such as annual health checkups and gym memberships are no longer sufficient to address modern workplace health challenges. Rising stress levels, sedentary routines and burnout have pushed organisations to adopt preventive, sustainable wellness strategies. One of the most effective among these is weekly onsite yoga.

Understanding how onsite yoga weekly benefits corporate wellness highlights why this ancient practice has become a modern workplace necessity. Yoga addresses both physical and mental health, making it uniquely suited for today’s high-pressure corporate environments.

Why Corporate Wellness Needs Preventive Solutions

According to the Indian Council of Medical Research (ICMR) and workplace health reports, lifestyle-related disorders such as hypertension, diabetes, obesity and mental health conditions are increasingly affecting working professionals.

Key workplace health challenges include:

prolonged sitting
poor posture
chronic stress
sleep disturbances
reduced physical activity

Preventive interventions are essential to reverse these trends before they result in chronic disease and productivity loss.

What Is Weekly Onsite Yoga?

Weekly onsite yoga involves structured yoga sessions conducted at the workplace by trained instructors. These sessions typically include:

stretching and mobility exercises
breathing techniques
simple yoga postures
relaxation and mindfulness practices

Sessions are designed to be inclusive, requiring no prior yoga experience.

Why Weekly Frequency Matters

Consistency is the foundation of wellness.

Weekly yoga sessions:

reinforce healthy habits
prevent accumulation of stress
support gradual physical improvement
encourage long-term participation

Unlike one-time workshops, weekly programs deliver sustained impact.

Physical Health Benefits of Onsite Yoga

Reduces Musculoskeletal Problems

Desk-based work often leads to back pain, neck stiffness and joint discomfort. Yoga improves:

posture
flexibility
muscle strength

This reduces work-related musculoskeletal disorders.

Improves Cardiovascular and Metabolic Health

Regular yoga practice supports:

blood pressure regulation
improved circulation
better glucose control

WHO recognises yoga and similar mind-body practices as beneficial for lifestyle disease prevention.

Enhances Energy Levels

Yoga improves oxygenation and circulation, reducing fatigue and mid-day energy crashes.

Mental Health Benefits in the Workplace

Reduces Stress and Burnout

Yoga lowers cortisol levels and activates the parasympathetic nervous system, promoting relaxation.

This helps employees:

manage deadlines calmly
recover from mental fatigue
reduce anxiety

Improves Focus and Cognitive Performance

Breathing and mindfulness practices improve:

attention span
mental clarity
decision-making

Better focus directly translates into improved productivity.

Supports Emotional Wellbeing

Regular yoga enhances emotional regulation, reducing irritability and improving workplace relationships.

Impact on Productivity and Performance

Healthy employees perform better.

Weekly onsite yoga contributes to:

reduced absenteeism
fewer stress-related sick days
improved work engagement
sustained productivity

EY-FICCI corporate wellness studies show that preventive wellness programs deliver measurable performance benefits.

Role in Building a Wellness-Oriented Culture

Onsite yoga sends a strong message that employee wellbeing is a priority.

It helps organisations:

foster trust and engagement
encourage work-life balance
create a supportive environment

Wellness culture improves retention and employer branding.

Inclusivity and Accessibility

One of yoga’s biggest strengths is adaptability.

Onsite yoga:

suits all age groups
accommodates different fitness levels
requires minimal equipment
can be modified for health conditions

This inclusivity ensures broad participation.

Cost-Effectiveness and ROI

Compared to advanced medical interventions, onsite yoga is:

low-cost
scalable
preventive rather than reactive

By reducing long-term healthcare costs, yoga delivers high return on investment for employers.

Yoga as Part of Preventive Healthcare

Preventive healthcare focuses on reducing risk factors before disease develops.

Weekly onsite yoga supports prevention by:

lowering stress-related disease risk
improving metabolic health
encouraging active lifestyles
supporting mental resilience

NITI Aayog recognises workplace wellness as a key lever for national health improvement.

Integration with Corporate Wellness Programs

Onsite yoga works best when integrated with:

preventive health checkups
stress management initiatives
nutrition education
digital health tracking

Integrated programs deliver stronger outcomes than isolated activities.

Overcoming Common Barriers

Some organisations hesitate due to:

time constraints
perceived lack of interest
space concerns

However, short, well-structured sessions (30–45 minutes) overcome these challenges effectively.

Long-Term Impact on Organisations

Organisations that adopt weekly onsite yoga observe:

healthier workforce
reduced burnout
improved morale
better long-term healthcare outcomes

Lancet workplace health studies show that consistent mind-body interventions yield benefits within 6–12 months.

Conclusion

Understanding how onsite yoga weekly benefits corporate wellness reveals why it is more than a fitness activity—it is a preventive health strategy. By addressing physical strain, mental stress and lifestyle risks, weekly onsite yoga supports healthier employees, stronger productivity and sustainable wellness culture. In today’s demanding corporate environment, investing in regular yoga sessions is an investment in long-term organisational resilience and success.

References

ICMR – Workplace Health and Lifestyle Disease Reports
National Family Health Survey (NFHS-5) – Adult Health and Stress Indicators
NITI Aayog – Preventive Healthcare and Workplace Wellness Strategy
WHO – Physical Activity, Yoga and Mental Health Guideline
Lancet – Mind-Body Interventions and Workplace Health Outcomes
EY-FICCI – Corporate Wellness and Productivity Report
Statista – Corporate Wellness Program Trends India

Request A Callback

+91

By using this website/app, I confirm that I am at least 18 years old and consent to the processing of my personal data in accordance with the Terms of Service, Privacy Policy, and Declaration.